Literature DB >> 10701035

The use of orbital morphine for postoperative analgesia in pterygium surgery.

K Wishaw1, D Billington, D O'Brien, P Davies.   

Abstract

A prospective double-blind study compared the analgesic effectiveness of peribulbar lignocaine with peribulbar morphine and lignocaine for postoperative analgesia in pterygium surgery. Twenty patients were randomly divided to receive a peribulbar injection preoperatively of either 1% lignocaine 2 ml or 1% lignocaine 1.6 ml and 4 mg morphine. Effects on pain at injection and pain at 24 hours and 48 hours postoperatively were measured with a visual analog pain scale. Effects of the injections on sedation, pupil size and unwanted side-effects were also recorded. The groups were comparable for age, weight and surgical technique. There was a significantly lower pain score at 24 hours after operation in the morphine group (P = 0.035). There were no significant differences in sedation or side-effects between the groups. The physiological effects of morphine on the eye are reviewed. The study suggests that orbital morphine may be an effective and safe form of analgesia for corneal surgery and further investigation is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701035     DOI: 10.1177/0310057X0002800107

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  10 in total

Review 1.  Peripheral opioid analgesia: clinical applications.

Authors:  Jochen Oeltjenbruns; Michael Schäfer
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 2.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

3.  Efficacy and safety of patching vs bandage lens on postoperative pain following pterygium surgery.

Authors:  S N Yeung; A Lichtinger; P Kim; U Elbaz; J Y F Ku; J C Teichman; M D Amiran; A R Slomovic
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

4.  Application of autologous serum eye drops after pterygium surgery: a prospective study.

Authors:  Sabahattin Sul; Safak Korkmaz; Goksu Alacamli; Pelin Ozyol; Erhan Ozyol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-18       Impact factor: 3.117

5.  Cultured human ocular surface epithelium on therapeutic contact lenses.

Authors:  Nick Di Girolamo; Jeanie Chui; Denis Wakefield; Minas T Coroneo
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

6.  Therapeutic contact lenses vs. tight bandage patching and pain following pterygium excision: a prospective randomized controlled study.

Authors:  Daphna Prat; Ofira Zloto; Elad Ben Artsi; Guy J Ben Simon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-01       Impact factor: 3.117

7.  Cut and paste: a no suture, small incision approach to pterygium surgery.

Authors:  G Koranyi; S Seregard; E D Kopp
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

8.  Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist.

Authors:  Brian D Bates; Kendall Mitchell; Jason M Keller; Chi-Chao Chan; William D Swaim; Ruth Yaskovich; Andrew J Mannes; Michael J Iadarola
Journal:  Pain       Date:  2010-04-18       Impact factor: 7.926

9.  A Randomized Controlled Trial to Manage Postoperative Ocular Pain after Pterygium Excision with Conjunctival Autograft Transplantation with a Single Application of 2% Sodium Hyaluronate.

Authors:  Winai Chaidaroon; Sirawit Isipradit; Phit Upaphong; Chutikarn Dejkriengkraikul
Journal:  Pain Res Manag       Date:  2022-06-27       Impact factor: 2.667

10.  Topical Antinociceptive Effect of Vanillosmopsis arborea Baker on Acute Corneal Pain in Mice.

Authors:  Laura Hévila Inocêncio Leite; Gerlânia de Oliveira Leite; Thales Silva Coutinho; Severino Denício Gonçalves de Sousa; Renata Souza Sampaio; José Galberto Martins da Costa; Irwin Rose Alencar de Menezes; Adriana Rolim Campos
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-10       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.